UBS Group’s CytRx Corp CYTR Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTR
UBS Group's CYTR Position: Q2 2019 in Review
UBS Group sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 2,389 shares — an estimated $2K sold.
UBS Group first reported a position in CYTR in Q4 2014 and held it in 18 quarters. The position peaked at $34K in Q2 2016. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.
- UBS Group reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
- UBS Group sold 2,389 CytRx Corp shares in Q2 2019, an estimated $2K.
- UBS Group first reported a position in CytRx Corp in Q4 2014 and held it in 18 quarters.
- UBS Group's CytRx Corp position peaked at $34K in Q2 2016.
- 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.